KPTI - Karyopharm Therapeutics Inc Stock quote - CNNMoney.com Find real-time KPTI - Karyopharm Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. KPTI - Karyopharm Therapeutics Inc Stock quote - CNNMoney.com Markets Karyopharm Therapeutics Inc. Common Stock (KPTI) After ... Karyopharm Therapeutics Inc. Common Stock (KPTI) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
Nov 10, 2019 · Their average twelve-month price target is $30.71, suggesting that the stock has a possible upside of 71.59%. The high price target for KPTI is $43.00 and the low price target for KPTI is $25.00. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in …
KPTI | Karyopharm Therapeutics Inc. Advanced Charts ... Karyopharm Therapeutics Inc. advanced stock charts by MarketWatch. View KPTI historial stock data and compare to other stocks and exchanges. Karyopharm Therapeutics Inc. Stock Price (KPTI) | Barron's View today's stock price, news and analysis for Karyopharm Therapeutics Inc. (KPTI). Barron's also provides information on historical stock ratings, target prices, company earnings, market KPTI Stock News - Fidelity
KPTI Karyopharm Therapeutics Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities …
KPTI:NASDAQ GS Stock Quote - Karyopharm Therapeutics Inc ... Stock analysis for Karyopharm Therapeutics Inc (KPTI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Karyopharm Therapeutics Inc. (KPTI) Stock Price, Quote ...
KPTI Stock Analysis Overview . What this means: Karyopharm Therapeut (KPTI) gets an Overall Rank of 75, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
KPTI Stock Summary. With a price/sales ratio of 32.46, Karyopharm Therapeutics Inc has a higher such ratio than 96.45% of stocks in our set. As for revenue Company Name: Karyopharm Therapeutics Inc., Stock Symbol: KPTI, Industry: Biotechs, Total Posts: 120, Last Post: 3/2/2020 5:33:48 PM. 4 Nov 2019 At last check, KPTI stock is up 8.2% at $13.56, and options traders are going wild. Leerink chimed in with a price-target hike to $17 from $15. Stock analysis for Karyopharm Therapeutics Inc (KPTI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company KARYOPHARM THERAPEUTICS INC SAYS OFFERING SHARES OF CO'S COMMON STOCK WITH AN AGGREGATE OFFERING PRICE OF $125 MILLION 23 May 2019 The chart below shows insider transactions (by individuals) over the last year. If you click on NasdaqGS:KPTI Recent Insider Trading, May 22nd 2019 But note: Karyopharm Therapeutics may not be the best stock to buy. Current, Vs Industry, Vs History. 3-Year Average Share Buyback Ratio, -13.9. Valuation & Return. Current, Vs Industry, Vs History. Price-to-Tangible-Book, 25.67.
KPTI -- Is Its Stock Price A Worthy Investment? Learn More.
Karyopharm Therapeutics Inc. (KPTI) Interactive Stock ... Karyopharm Therapeutics Inc. (KPTI), an oncology-focused pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to KPTI Stock Price and Chart — NASDAQ:KPTI — TradingView View live KARYOPHARM THERAPEUTICS INC chart to track its stock's price action. Find market predictions, KPTI financials and market news.